Srihari S. Naidu, MD

Perspectives

Here Comes the Sun: Physician Relationships With Industry and the Sunshine Act

05/30/2014

For several years now, physicians, professional societies, and the pharmaceutical and device industries have been concerned about a part of the Affordable Care Act called the Sunshine Act.

For several years now,...

05/30/2014

EP Lab Digest

Commentary

The Declining Relevance of Age in the Treatment of Atrial Septal Defects

08/01/2008

Srihari S. Naidu , MD;

Atrial septal defects (ASD), which comprise roughly 10% of all congenital cardiac disease, are frequently first encountered in the adult population.1 Significant shunting results in the insidious development of symptoms, culminating in overt...

Atrial septal defects (ASD),...

08/01/2008

Journal of Invasive Cardiology

HCM Techniques

Teamwork Drives Success: Alcohol Septal Ablation for the Treatment of Hypertrophic Cardiomyopathy at Westchester Medical Center

05/01/2018

Robert Timmermans , MD;

Julio A. Panza , MD, FACC, FAHA;

Srihari S. Naidu , MD;

Jason Jacobson , MD;

Kellee Lefco , RN;

Gabbie Fried ;

Angelica Poniros , RCS;

Tanya Dutta , MD;

Dr. Srihari S. Naidu and colleagues discuss the Hypertrophic Cardiomyopathy Program at Westchester Medical Center.

Dr. Srihari S. Naidu and...

05/01/2018

EP Lab Digest

Invasive Thoughts

Making Up For Lost Time: STEMI Care in 2012

10/02/2012

Srihari S. Naidu , MD;

As I write this, it’s Monday after a relatively busy weekend on call. Kicking off the weekend, last Friday morning we had our monthly “Acute Myocardial Infarction — 911” meeting, our lingo for the door-to-balloon initiative. For the past 10...

As I write this, it’s Monday...

10/02/2012

Journal of Invasive Cardiology

Teamwork Drives Success: Alcohol Septal Ablation for the Treatment of Hypertrophic Cardiomyopathy at Westchester Medical Center

10/03/2017

Kellee Lefco , RN;

Gabbie Fried ;

Angelica Poniros , RCS;

Tanya Dutta , MD;

Robert Timmermans , MD;

Julio A. Panza , MD, FACC, FAHA;

Srihari S. Naidu , MD;

Jason Jacobson , MD;

Team approaches are evolving, but require at a minimum advanced imaging, defined HCM protocols, and the full armamentarium of management options.

Team approaches are evolving,...

10/03/2017

Cath Lab Digest

Commentary

Three Years Since the FDA Advisory Panel on Drug-Eluting Stents: What Have We Learned about Off-Label Use and Stent Thrombosis?

01/07/2010

Srihari S. Naidu , MD;

The arrival of drug-eluting stents in interventional cardiovascular practice heralded a new era in the management of patients with symptomatic coronary artery disease. Indeed, while bare metal stents were a clear technological breakthrough,...

The arrival of drug-eluting...

01/07/2010

Journal of Invasive Cardiology

Invasive Thoughts

Thoughts on the Future of the Interventional Cardiology Workforce

02/27/2013

Srihari S. Naidu , MD;

Where is the field going, and should there be more or fewer interventional cardiologists, considering the current landscape and the number of physicians interested in joining the ranks?

Where is the field going, and...

02/27/2013

Journal of Invasive Cardiology